After seeing few updates for more than two decades, treatment options for ovarian cancer are beginning to expand rapidly. As doctors and scientists have learned more about the molecular forces at work in ovarian cancer, and about the immune system’s role in fighting the disease, several new therapies are being used, either as FDA-approved drugs … Read more
Leukemia is a blood cancer that results when stem cells in the bone marrow produce abnormal blood cells.
It’s not uncommon for cancer patients to take to a pen after a diagnosis. Peter Rooney’s taken that to another level. Rooney, a former journalist and author of the book Die Free, captured his cancer journey in the new book Immunopatient: The New Frontier of Curing Cancer. The following excerpt is reprinted with permission from Immunopatient by … Read more
With more people living longer than ever with chronic or serious illnesses, grandparents with cancer are a rapidly growing group. Here are some tips for how children of almost any age can support a grandmother or grandfather facing cancer. If it has been sometime since you saw your grandparent or the treatment has changed their … Read more
This originally appeared on Vector, Boston Children’s Hospital’s blog. A novel screening method using CRISPR-Cas9 genome editing technology has revealed new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy. The method, developed by a team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, uses … Read more
Sarah Murray was planning her wedding when she was diagnosed with breast cancer at age 29 and became a patient in the Young Women with Breast Cancer program at Dana-Farber’s Susan F. Smith Center for Women’s Cancers. “Cancer was the furthest thing from our minds,” she recalls. Like many other young women in her shoes, … Read more
By Ursula Matulonis, MD, Chief, Division of Gynecologic Oncology Immunotherapy, which has revolutionized the treatment of many types of cancer, is undergoing extensive study in patients with ovarian cancer. Although much of this research is in the early stages, it has produced some intriguing findings about the promise of this approach to treatment. Clinical trials … Read more
Identical twins George and Greg Robinson have been inseparable for 57 years, from sharing a childhood bedroom and classes in school through dual Air Force stints and careers in the airline industry. Today, back in their native Cambridge, Mass., they live just a block apart and still talk several times daily. But there is one … Read more
It’s a compelling idea that has attracted scientists for decades: rather than poison tumors with chemicals and radiation, use a biological agent – a vaccine – to rally the body’s formidable immune defenders to kill cancer cells and shrink tumors. Yet, even as other forms of immunotherapy are showing promise against some cancers, efforts to … Read more
The U.S. Food and Drug Administration (FDA) has signed off on a new targeted treatment for some patients with acute myeloid leukemia (AML), an often aggressive disease and the most common adult acute leukemia. The FDA approved the drug Idhifa (enasidenib) specifically for the treatment of adult patients with relapsed or refractory AML who have … Read more
Melanoma is a rare form of skin cancer that typically begins in a mole. It can occur anywhere on the body, and although it is the least common type of skin cancer, it is more likely to spread to other parts of the body and, ultimately, cause death. Within the United States, Utah has the … Read more
At Dana-Farber, radiation oncologists like Dr. David Kozono, MD, PHD work to improve outcomes in cancer through research and deliver quality care to patients through radiation therapy. About two-thirds of cancer patients undergo radiation therapy as part of their treatment. What new developments are occurring in the world of radiation? According to Kozono, technological advances … Read more
By James Tulsky, MD James Tulsky, MD, is chair of Psychosocial Oncology and Palliative Care at Dana-Farber, with a longstanding research interest in clinician-patient communication and quality of life for patients with serious illnesses. He is also founding director of VitalTalk, a non-profit with a mission to nurture healthier connections between clinicians and patients through … Read more
Cancer researchers continue to explore why cancer occurs in the body – and how to stop it before it shows up. Tools like genetic testing, which looks for alterations, or mutations, in a person’s genes, can help determine whether a person is more likely to develop certain kinds of cancer. But researchers have also identified … Read more
At first, early intervention specialists told Christi Powers that her young son’s gross motor delays and poor balance were likely the result of weak muscle tone, but when Danny developed severe headaches at age 4, she took him to the emergency room. Soon the suburban Boston boy was diagnosed with a low-grade glioma, the most … Read more
Medically reviewed by Mark Pomerantz, MD Prostate-specific antigen, or PSA, is a protein naturally produced by the prostate gland in men. Because prostate cancer can increase the level of PSA in the blood, many doctors and professional organizations recommend that men over age 50 receive a PSA test in conjunction with a digital rectal exam … Read more
With an estimated 8,500 new cases of skin cancer diagnosed in the U.S. every day, it is important that you not only protect yourself from the sun’s UV rays, but also regularly check your skin for anything out of the ordinary. While freckles and moles are often harmless, it is important to perform regular self-exams … Read more
Having a child diagnosed with a life-threatening illness is heart-wrenching for all parents, but when the diagnosis itself is uncertain, parents can face excruciatingly difficult decisions. This is what Katie and Josh Stevens of Idaho confronted after their son Riley was diagnosed in October 2012 with the blood disorder aplastic anemia, in which the body’s … Read more
Moles are benign growths on the skin that sometimes become cancerous. But what exactly is the connection between moles and melanoma, the most aggressive skin cancer? While it’s true that people with many moles should be screened more frequently by a dermatologist, scientists are learning that the mole-melanoma connection isn’t so straightforward. For example, a … Read more
Just over a month after approving a first-of-its-kind combination therapy for advanced melanoma, the U.S. Food and Drug Administration (FDA) has signed off on another drug combination to treat the disease. The FDA has approved a targeted therapy combination, Cotellic (cobimetinib) and vemurafenib, to treat advanced melanoma that has spread to other parts of the … Read more